Literature DB >> 20644087

No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia.

Iris H I M Hollink, Marry M van den Heuvel-Eibrink, Martin Zimmermann, Brian V Balgobind, Susan T C J M Arentsen-Peters, Marielle Alders, Andre Willasch, Gert-Jan J L Kaspers, Jan Trka, Andre Baruchel, Ursula Creutzig, Rob Pieters, Dirk Reinhardt, C Michel Zwaan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20644087     DOI： 10.1200/JCO.2010.29.3860

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  Low frequency of type-I and type-II aberrations in myeloid leukemia of Down syndrome, underscoring the unique entity of this disease.

Authors:  Marjolein Blink; Marry M van den Heuvel-Eibrink; Valerie de Haas; Jan-Henning Klusmann; Henrik Hasle; C Michel Zwaan
Journal:  Haematologica       Date:  2012-04       Impact factor: 9.941

2.  Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Authors:  Heiko Becker; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Klaus H Metzeler; Susan P Whitman; Sebastian Schwind; Jessica Kohlschmidt; Yue-Zhong Wu; Bayard L Powell; Thomas H Carter; Jonathan E Kolitz; Meir Wetzler; Andrew J Carroll; Maria R Baer; Joseph O Moore; Michael A Caligiuri; Richard A Larson; Guido Marcucci; Clara D Bloomfield
Journal:  Haematologica       Date:  2011-06-09       Impact factor: 9.941

3.  Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study.

Authors:  Eva A Coenen; Susana C Raimondi; Jochen Harbott; Martin Zimmermann; Todd A Alonzo; Anne Auvrignon; H Berna Beverloo; Myron Chang; Ursula Creutzig; Michael N Dworzak; Erik Forestier; Brenda Gibson; Henrik Hasle; Christine J Harrison; Nyla A Heerema; Gertjan J L Kaspers; Anna Leszl; Nathalia Litvinko; Luca Lo Nigro; Akira Morimoto; Christine Perot; Dirk Reinhardt; Jeffrey E Rubnitz; Franklin O Smith; Jan Stary; Irina Stasevich; Sabine Strehl; Takashi Taga; Daisuke Tomizawa; David Webb; Zuzana Zemanova; Rob Pieters; C Michel Zwaan; Marry M van den Heuvel-Eibrink
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

4.  Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.

Authors:  Brian V Balgobind; Iris H I M Hollink; Susan T C J M Arentsen-Peters; Martin Zimmermann; Jochen Harbott; H Berna Beverloo; Anne R M von Bergh; Jacqueline Cloos; Gertjan J L Kaspers; Valerie de Haas; Zuzana Zemanova; Jan Stary; Jean-Michel Cayuela; Andre Baruchel; Ursula Creutzig; Dirk Reinhardt; Rob Pieters; C Michel Zwaan; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

5.  Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.

Authors:  Anne-Sophie Junghanns; Susan Wittig; Caroline Woehlecke; Thomas Lehmann; Clemens Arndt; Bernd Gruhn
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-30       Impact factor: 4.553

Review 6.  A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia.

Authors:  J E Megías-Vericat; M J Herrero; L Rojas; P Montesinos; V Bosó; F Moscardó; D Martínez-Cuadrón; J L Poveda; M Á Sanz; S F Aliño
Journal:  Pharmacogenomics J       Date:  2015-12-08       Impact factor: 3.550

7.  Risk-Reducing Genetic Variant of Wilms Tumor 1 Gene rs16754 in Korean Patients With BCR-ABL1-Negative Myeloproliferative Neoplasm.

Authors:  Namhee Kim; In-Suk Kim; Chulhun L Chang; Jeong-Eun Kang; Eun Yup Lee; Ho-Jin Shin
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

Review 8.  The Wilms Tumor-1 (WT1) rs16754 polymorphism is a prognostic factor in acute myeloid leukemia (AML): a meta-analysis.

Authors:  Jianting Long; Shi Fang; Qiangsheng Dai; Xiaolian Liu; Wanshou Zhu; Shenming Wang
Journal:  Oncotarget       Date:  2016-05-31

9.  Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma.

Authors:  Xingru Li; Sihan Wang; Raviprakash T Sitaram; Charlotta Andersson; Börje Ljungberg; Aihong Li
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.